Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe) (ReVe)
Congestive Heart Failure, Defibrillators, Cardiac Resynchronization Therapy
About this trial
This is an interventional prevention trial for Congestive Heart Failure focused on measuring remote monitoring, congestive heart failure, Defibrillators, cardiac resynchronization therapy
Eligibility Criteria
Inclusion Criteria: consented heart failure patients (LVEF<=40%) with Biotronik wireless monitoring capable ICD/CRTs aged >20 years patients who are new to remote monitoring Exclusion Criteria: For patients with a life expectancy of less than 6 months. If patient do not understand the contents of wireless monitoring or it is difficult to fill out the consent form due to cognitive decline. If wireless monitoring is performed with a patient enrolled in another clinical trial which remote monitoring may affect the previous enrolled study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Follow up group
Remote group
participants with experience of >6 months in-office device interrogation, then started remote monitoring
participants with newly implanted device with study agreement, and then started remote monitoring